Navigation Links
Align Technology Names Dana C. Cambra as VP, Research & Development

SANTA CLARA, Calif., May 19 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN), today announced that it has hired Dana C. Cambra as vice president of research and development, effective June 16. Mr. Cambra will report directly to Align President and Chief Executive Officer, Thomas M. Prescott and lead the Company's research and development initiatives.

"Product innovation is Align's highest priority and we are pleased to have Dana on board to lead the team responsible for developing and executing our research initiatives and product roadmap," said Thomas M. Prescott, Align president and CEO. "Dana's extensive experience in medical technology and software development will be of tremendous value to Align as we continue our history of innovation and build the next generation of Invisalign products."

Innovation has been a hallmark of Mr. Cambra's career. As a member of the management and technical teams at Acuson Corporation, now a Siemens Company, he was instrumental in the development of the Sequoia Medical Diagnostic Ultrasound system, a breakthrough in high-resolution ultrasound products that has generated more than $4 billion in revenue.

More recently, Mr. Cambra served as senior vice president, research and development for Pharsight Corporation, a leading provider of simulation and modeling software for pharmaceutical and biotechnology companies. Prior to his role at Pharsight, Mr. Cambra was vice president, engineering at Stentor Inc. and the Phillips Global PACS business unit, an industry leader in providing medical informatics solutions. Earlier roles included senior engineering and operations positions at Visto, where he led development of communications solutions for the first Handspring/Palm Treo device, and iScribe, where he led the development of an industry leading ePrescribing solution.

Mr. Cambra received his undergraduate degrees in mathematics and engineering from MIT and his graduate degree in engineering from UC Berkeley.

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and older teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998.

To learn more about Invisalign or to find a certified Invisalign doctor in your area, please visit or call 1-800-INVISIBLE.

Investor Relations Contact Press Contact

Shirley Stacy Shannon Mangum Henderson

Align Technology, Inc. Ethos Communication, Inc.

(408) 470-1150 (678) 540-9222

SOURCE Align Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. US Oncology Applauds Journal of Clinical Oncology Study Highlighting Value of PET Scans for Cancer Patients With Various Types of Malignancies
2. NUCRYST Announces Management Realignment and R&D Portfolio Change
3. New regulatory circuit identified for aggressive, malignant brain tumor
4. Malignant tumor or benign cyst?
5. Is Cancer Community in Alignment About Cure and Costs? NCCN Conference Panel Asks
6. Protein in Human Embryonic Stem Cells Controls Malignant Tumor Cells
7. Protein in embryonic stem cells control malignant tumor cells
8. ULLICO Casualty Group Aligns with Hudson Insurance Company to Offer Fiduciary and Union Liability Insurance
9. Alessi Skin Care Aligns With Celebrity Socialite Fabian Basabe to Raise Awareness for Their Face Forward Campaign
10. InterComponentWare Inc. Aligns with the Center for Health Transformation
11. Align Technology Executives to Present at Upcoming Financial Conferences
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... The McHenry County law firm of ... obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer ... 2015 IL App (2d) 130884WC. , According to court documents, Adcock testified that on ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, ... facial plastic surgeon specializing in both surgical and non-surgical treatments, announced the expansion ... at Hobgood Facial Plastic Surgery. , Highly trained and nationally recognized for ...
(Date:11/25/2015)... MI (PRWEB) , ... November 25, 2015 , ... In ... Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy ... medical and surgical intensive care units (totaling 30 beds) from May 2014 through October ...
(Date:11/25/2015)... ... November 25, 2015 , ... Castlewood Treatment Center ... with eating disorders as a result of the $20,000 raised at the center’s ... Fox Run Golf Club in Eureka, will help individuals who otherwise might not ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately owned Contract Development ... expansion of its current state of the art research, development and manufacturing facility ... increase its manufacturing capacity as well as to support its clients’ growing research ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 ... the addition of the "2016 Future Horizons ... Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, ... offering. --> ... comprehensive analysis of the Italian therapeutic drug monitoring ...
(Date:11/25/2015)... OAKS, Calif. , Nov. 25, 2015  Amgen ... a Biologics License Application (BLA) with the ... (FDA) for ABP 501, a biosimilar candidate to Humira ... first adalimumab biosimilar application submitted to the FDA and ... pathway. Sean E. Harper , M.D., executive ...
Breaking Medicine Technology: